Publications in collaboration with researchers from Ikerbasque, Fundación Vasca para la Ciencia (35)

2024

  1. Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative

    CRISPR Journal, Vol. 7, Núm. 5, pp. 220-226

  2. Re-defining the human embryo: A legal perspective on the creation of embryos in research

    EMBO Reports, Vol. 25, Núm. 2, pp. 467-470

  3. Use of AI Tools for Forensic Purposes: Ethical and Legal Considerations from an EU Perspective

    Driv. Forensic Innovation in the 21st Century: Crossing the Valley of Death (Springer International Publishing), pp. 147-164

2023

  1. The EU legal framework on clinical trials directed to therapeutic germline gene alteration: A critical and systematic analysis

    Medical Law International, Vol. 23, Núm. 1, pp. 44-70

2022

  1. Mandatory vaccination and the ‘seat belt analogy’ argument: a critical analysis in the context of the Covid-19 pandemic

    Medicine, Health Care and Philosophy, Vol. 25, Núm. 2, pp. 219-224

2021

  1. Addressing organ shortage: An automatic organ procurement model as a proposal

    Clinical Ethics, Vol. 16, Núm. 4, pp. 278-290

  2. The Geneva Statement on Heritable Human Genome Editing: A Criticism

    Trends in Biotechnology

  3. Vaccination certificates, immunity passports, and test-based travel licences: Ethical, legal, and public health issues

    Travel Medicine and Infectious Disease

  4. We should not vaccinate the young to protect the old: A response to Giubilini, Savulescu, and Wilkinson

    Journal of Law and the Biosciences, Vol. 8, Núm. 1

  5. What Can We Do with the Data of Deceased People? A Normative Proposal

    European Review of Private Law, Vol. 29, Núm. 5, pp. 785-806

2020

  1. 'Digital pills' for mental diseases: An ethical and social analysis of the issues behind the concept

    Journal of Law and the Biosciences, Vol. 7, Núm. 1

  2. Gene editing and disabled people: a response to Felicity Boardman

    Journal of Community Genetics, Vol. 11, Núm. 3, pp. 241-243

  3. Human Dignity and Gene Editing: Additional Support for Raposo’s Arguments

    Journal of Bioethical Inquiry, Vol. 17, Núm. 2, pp. 165-168

  4. Immunity passports, fundamental rights and public health hazards: A reply to Brown et al

    Journal of Medical Ethics, Vol. 46, Núm. 10, pp. 660-661

  5. Is the serious' factor in germline modification really relevant? A response to Kleiderman, Ravitsky and Knoppers

    Journal of Medical Ethics, Vol. 46, Núm. 2, pp. 151-152

  6. Machine learning in the EU health care context: exploring the ethical, legal and social issues

    Information Communication and Society, Vol. 23, Núm. 8, pp. 1139-1153

  7. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective

    Bioethics, Vol. 34, Núm. 1, pp. 16-32

  8. Should we have a right to refuse diagnostics and treatment planning by artificial intelligence?

    Medicine, Health Care and Philosophy, Vol. 23, Núm. 2, pp. 247-252

2019

  1. Comment on "Should gene editing replace embryo selection following PGD? Some comments on the debate held by the International Society for Prenatal Diagnosis"

    Prenatal Diagnosis

  2. Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?

    Science and Engineering Ethics